About Arcensus
Arcensus is a company based in Rostock (Germany) founded in 2021 by Michael Schlenk and Arndt Rolfs was acquired by Dammam Valley in September 2022. Arcensus offers products and services including myLifeGenome, myLifeExome, and Data2Report. Arcensus operates in a competitive market with competitors including BodyClock, Molecular Life, GeneLinx, DNAid Diagnostics and Lia Health, among others.
- Headquarter Rostock, Germany
- Founders Michael Schlenk, Arndt Rolfs
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Arcensus Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
MBG MV
& 1 more
-
Employee Count
Not available
-
Acquired by
Dammam Valley
(Sep 05, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Arcensus
Arcensus offers a comprehensive portfolio of products and services, including myLifeGenome, myLifeExome, and Data2Report.
Whole genome sequencing for personalized health insights.
Exome sequencing to identify rare genetic disorders.
Platform for generating and accessing clinical reports.
People of Arcensus
Unlock access to complete
Funding Insights of Arcensus
Investors in Arcensus
Arcensus has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include MBG MV and Dammam Valley.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Financial support is provided to SMEs in Mecklenburg-Vorpommern.
|
Locked | Locked | Locked | |
|
Investment arm of Imam Abdulrahman Bin Faisal University, focused on future industries.
|
Locked | Locked | Locked |
Investor details for Arcensus
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Arcensus
Investment portfolio details for Arcensus
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Arcensus
Detailed financials for Arcensus
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Arcensus Comparisons
Peer comparison for Arcensus
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Arcensus
Arcensus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BodyClock, Molecular Life, GeneLinx, DNAid Diagnostics and Lia Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of RNA-based hair test for personalized sleep and lifestyle recommendations
|
|
| Locked | Locked | Locked |
Offers genetics-based personalized health recommendations.
|
|
| Locked | Locked | Locked |
Provides personalized genetic counseling and testing for health risks and family planning.
|
|
| Locked | Locked | Locked |
Operates a diagnostic lab for detecting cancer through blood tests.
|
|
| Locked | Locked | Locked |
An AI-based app designed for effective health management and monitoring.
|
Detailed competitors of Arcensus
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Arcensus
Complete news archive for Arcensus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arcensus
Arcensus was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Arcensus is headquartered in Rostock, Germany. It is registered at Rostock, Mecklenburg-vorpommern, Germany.
Shivendra Kishore is the current CEO of Arcensus.
Arcensus was founded in 2021 in Rostock, Germany, within the genetic diagnostics sector. Test kits are provided for analyzing cardiac and cancer-related genes, including myLife Heart, myLife Cancer, and myLifeDNA. Medical counseling is delivered by professionals to support users. Operations focus on direct-to-consumer genetic testing services in Europe.
Arcensus's top competitors include BodyClock, Molecular Life and GeneLinx.
Arcensus offers myLifeGenome, myLifeExome, and Data2Report.
Arcensus has 2 investors. Key investors include MBG MV, and Dammam Valley.